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Unfortunately, the best available imaging modalities 
usually cannot detect lesions smaller than 3 ram. Despite 
this small size, these "little" cancers already are mature, 
virulent, and lethal. 
In case 2, the patient really had an open lobectomy and 
lymph node resection for a lesion with ulceration of the 
visceral surface. These ulcerating lesions have a notori- 
ously poor prognosis. Many surgeons will routinely do a 
wedge resection of a lesion for frozen section and diag- 
nosis at thoracotomy before resecting. Should this be 
avoided for fear of disseminating tumor? Even worse, 
some will even use needle aspiration at thoracotomy, 
probably dropping cells in the pleural space. I fail to see 
any relation between VATS and carcinomatosis when a 
recognized virulent lesion, with an exceedingly poor prog- 
nosis, is resected by open lobectomy. 
Buhr and associates 3 have reported preresectional, pos- 
itive results of cytologic lavage in the open chest in the 
past. Might this same situation not occur with VATS? 
Most likely, it is the biologic characteristics of the tumor 
that determine this finding, not the surgical technique. 
Unfortunately, cancer does not follow any anatomic tissue 
planes consistently. Patterns of spread and metastasis 
have always been haphazard and unpredictable. Scientific 
studies are not convincing that lymph nodes play any role 
in improving survival. 4 
Buhr and associates have only 21 cases of malignancy, 
and 14 of these were metastatic. Were the two cases 
described in their communication from the metastatic 
group? Should patients with known metastatic lesions, 
which are disseminating, be included in reports on port 
implants? 
In the past, surgeons frequently changed gloves and 
gowns and washed instruments, hoping to diminish tumor 
contamination. These maneuvers had minimal effect on 
curtailing the spread of tumor. Although some procedures 
seem to have the potential for spreading malignant cells, 
they are accepted and practiced by all surgeons. Medias- 
tinoscopy with biopsy for malignancy has a wound implan- 
tation incidence of only 0.1% even though exposed tumor 
traverses the entire mediastinum and neck. 5 Malignant 
cells are found in needle tracts in 89% of patients after 
percutaneous lung biopsy, yet chest wall implants occur in 
only 1 in 2,500 cases. Bronchoscopy with biopsy, esopha- 
goscopy with biopsy, and even colonoscopy with biopsy 
expose an injured, traumatized, regenerating mucosa to 
malignant cells; however, all surgeons perform these 
techniques and apparently are not concerned with tumor 
implantation. Transhiatal esophagectomy finger fractures 
the tumor and then "drags" the neoplasm through the 
mediastinum. Survivals after radical esophagectomy b
left thoracotomy, Nor Lewis esophagectomy, or transhia- 
tal esophagectomy are all similar at 20%. 6 
Successful tumor implantation in the laboratory re- 
quires transgenic mice.7Rare and specific genetic muta- 
tions seem necessary before tumor spread and implan- 
tation can occur in human beings. Possibly, port 
implantation could be the first manifestation of systemic 
spread. In fact, after careful examination, tumor implants 
have been found in thoracotomy wounds. Unfortunately, 
in many instances other more important areas of metas- 
tasis are present simultaneously, sothat the finding in the 
wound is irrelevant. 
Port implantation after VATS is a serious and complex 
problem that we must all study carefully so that the 
etiology can be determined. Simple touch implantation, 
making it analogous to infection, does not answer all of 
our questions. Possibly, implantation could be the result 
of unidentified and yet unknown genetic mutations rep- 
resenting the earliest signs of a virulent tumor that has 
already undergone hematogenous spread. We adamantly 
recommend a sealed container for the removal of all 
malignant issue, even though it might not prevent his 
problem if the underlying cause is truly related to biologic 
changes. 
Ralph J. Lewis, MD 
Robert J. Caccavale, MD 
Glenn E. Sisler, MD 
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Reply to the Editor." 
Thoracoscopy and video-assisted thoracic surgery 
(VATS) have been characterized as minimally invasive 
operations. Both techniques seems to decrease operative 
trauma. 13 The indications for thoracoscopy and VATS, 
an obvious variation on the theme, continue to evolve. 
The growing enthusiasm for these minimally invasive 
surgical procedures has led to an expanded role in the 
diagnosis and staging of lung cancer. However, the role of 
thoracoscopy and VATS in the treatment of primary 
thoracic tumors or lung metastases is still undefined. 
Chest wall metastasis (case 1 in our brief communica- 
tion) or pleural carcinosis (case 2 in our brief communi- 
cation) are very unusual for stage I lung cancer. In our 
first case we did not place the resected specimen in a bag. 
I think that tumor cells were squeezed into the chest wall 
during the extraction procedure. For this reason, 11/2 years 
after the thoracoscopic resection, we detected a metastasis 
at the port site, the site of tumor extraction. After curative 
resection of the tumor located at the thoracic wall, the 
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patient is still free of any other tumor manifestation. 
Meanwhile, the second operation was nearly 2 years ago 
and we did. not find any other widespread metastases. 
Therefore, I think the metastasis at the thoracic wall was 
induced by thoracoscopic surgery, because we could not 
detect any signs of hematogenous dissemination. 
In our second case we performed a closed resection of 
an adenocarcinoma with infiltrationof the pleural surface. 
These two factors may induce subsequent pleural carci- 
nosis. Of course, tumors with infiltration of the pleural 
surface have a poorer prognosis than tumors without 
ulceration of the p!eural viscera. However, complete 
resection of these stage I tumors by open thoracic opera- 
tions is usually curative. In  our case of pleural carcinosis 
the result of pleural lavage cytology wa s positive after 
thoracoscopic resection. In the first lavage fluid (before 
thoracoscopic resection) we did not find any tumor cells. 
The dissemination of tumor cells into the pleural cavity 
with subsequent pleural carcinosis was the result of the 
close resection of the lung cancer by the thoracoscopic 
approach. 
To the present, we have performed intraoperative 
pleura 1lavage <s in 319 patients with lung cancer before 
(lavage I) and after (lavage II) open resection. Tumor 
cells were found in 122 cases (38.2%) in the !avage I
group. In 24.8% we detected tumor cells in stage I (pT1 
NO, pT2 NO) lung cancers. The cumulative survival of 
non-small-cell lung cancer in stage I (n = 154) was 22.1% 
if the results of !avage were positive (n = 44) and 67.9% 
if lavage results were negative (n = 110) (p < 0.05). The 
biologic behavior of lung cancer and the irregular patterns 
of spread determine this finding. In our two cases of 
tumor dissemination after thoracoscopic resection of lung 
cancer, the cytologic result of pleural avage was positive 
only after the resection. 
Several reports of tumor implants after thoracoscopic 
resection of malignant tumors have been published. 6-s In 
all cases the authors uspected a relation between VATS 
and tumor dissemination. 
We have performed thoracoscopic resection of nodules 
of the lung in 108 cases. In 42 cases, malignancy was 
demonstrated (25 metastases and 17 primary lung can- 
cers). In most cases of lung cancer we converted tO open 
lung surgery with lobectomy or pneumonect0mY and 
additional ymph node dissection, which could.,fiot be 
performed sufficiently by a thoracoscopic approachi9' lo in 
our opinion thoracoscopic resection for potentially ma!ig- 
nant lesions should be restricted to superficial lesions 
smaller than 2 cm. If the thoracoscopic appearance sug- 
gests primary lung cancer with infiltration of the pleural 
surface, conversion to open procedure is absolutely nec- 
essary. 
J. Buhr, MD 
Department of General and Thoracic Surgery 
Justus Liebig University 
Rudolf-Buchheim-Strasse 7 
D,35392 Giessen, Germany 
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